http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-830630-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D201-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D201-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D201-04
filingDate 1957-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1960-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-830630-A
titleOfInvention Improvements in the production of lactams from oxime hydrochlorides
abstract A process for the production of lactams comprises allowing a sulphuric acid of 80 to 100% by weight which may contain up to 50% by weight of free sulphur trioxide dissolved therein to act on a hydrochloride of a cycloaliphatic ketoxime having a ring member number of 5 to 10 carbon atoms. A proportion of lactam may be added to the reactants to initiate the reaction. The reaction mixture may be neutralized with aqueous alkali metal or alkaline earth metal hydroxides or concentrated ammonia solution or gaseous ammonia. The liquid hydrochlorides formed by treating crystalline cycloaliphatic oxime hydrochlorides with hydrogen chloride may be employed as starting materials. Oximes, of which the hydrochlorides may be employed as starting materials, specified are cyclopentanone, cyclohexanone, methylcyclohexanone, cycloheptanone, cyclooctanone and cyclodecanone. The preparations of o -caprolactam, o -valerolactam and o -aenantholactam are described.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4932925-A
priorityDate 1956-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412215776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415751947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453327643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10400

Total number of triples: 42.